US equities |
MU $1,035.84 ▼-4.79% NVDA $230.48 ▼-2.94% SNDK $1,609.46 ▼-4.90% AMD $620.68 ▼-3.90% INTC $107.08 ▼-5.34% AAPL $340.42 ▲+1.11% META $720.89 ▼-0.06% SPCX $160.57 ▼-4.19%
FinancialContent

Latest News about CYB003

Recent news which mentions CYB003

Cybin Inc. Begins Phase 3 Trials, Betting Big On CYB003 To Treat Depression
Tickers CYBN
Tags neuropsychiatric treatment neuropsychiatry company CYBN
From Benzinga
Cybin Announces First Dosing In Human Trial With Proprietary Psychedelic Drug For Depression
Tickers CYBN
Tags Health Care Doug Drysdale Markets
From Benzinga
Major Depressive Disorder Could Soon Have Treatment Option Via Cybin's Psilocybin Analog
Tickers CYBN
Tags Psychedelics FDA News
From Benzinga